Department of Dermatology, University of California at San Francisco, San Francisco, CA, U.S.A.
Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, U.S.A.
Br J Dermatol. 2017 Nov;177(5):1202-1207. doi: 10.1111/bjd.15889. Epub 2017 Sep 26.
Long-term iatrogenic immunosuppression increases the risk of cutaneous malignancies in organ transplant recipients (OTRs), particularly the keratinocyte cancers basal cell carcinoma and cutaneous squamous cell carcinoma (cSCC). cSCC is the most common malignancy in OTRs, with the risk increased to over 65-fold in transplanted patients relative to the general population. There have been very few risk prediction tools developed for accurate determination of the risk of developing keratinocyte cancers in the OTR population. This review summarizes the prediction tools developed to date, and outlines future directions for developing more accurate prediction models that are clinically useful for the transplant physician and dermatologist.
长期医源性免疫抑制会增加器官移植受者(OTR)发生皮肤恶性肿瘤的风险,特别是角质形成细胞癌,包括基底细胞癌和皮肤鳞状细胞癌(cSCC)。cSCC 是 OTR 中最常见的恶性肿瘤,与普通人群相比,移植患者的风险增加了 65 倍以上。目前已经开发出了很少的风险预测工具来准确确定 OTR 人群中角质形成细胞癌的发病风险。本综述总结了迄今为止开发的预测工具,并概述了开发更准确预测模型的未来方向,这些模型对移植医生和皮肤科医生具有临床应用价值。